FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare Metronidazole Injection Recall

Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerf…

Baxter Healthcare Corp. · Deerfield, IL

Risk level
Class II
Reported by FDA
Jul 10, 2013
Recall ID
D-629-2013
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Metronidazole Injection starting May 21, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-629-2013 on Jul 10, 2013. Reason: Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Product description

Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48

Lot numbers, UPCs & expiration codes

Lot #: P280123, P280123A, Exp 2/14

Where it was sold

Nationwide & Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-629-2013
Classification
Class II
Status
Terminated
Recall initiated
May 21, 2013
FDA report date
Jul 10, 2013
Quantity
172,296 units
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corp.

Original FDA data

Every field from FDA enforcement report D-629-2013, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
65288
Address
1 Baxter Pkwy
Code information
Lot #: P280123, P280123A, Exp 2/14
Postal code
60015-4625
Report date
Jul 10, 2013
Product type
Drugs
Recall number
D-629-2013
Classification
Class II
Recalling firm
Baxter Healthcare Corp.
Product quantity
172,296 units
Termination date
Jun 18, 2015
Reason for recall
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48
Distribution pattern
Nationwide & Puerto Rico
Recall initiation date
May 21, 2013
Initial firm notification
Letter
Center classification date
Jun 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-629-2013, published Jul 10, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls